This analysis encapsulates the significant trends and strategic shifts observed within the Conestoga Micro Cap Composite during the second quarter of 2026. It delves into the robust performances of key holdings, underscoring the potential for substantial returns in the micro-cap segment by identifying resilient and growth-oriented enterprises capable of navigating diverse economic cycles.

Detailed Investment Commentary for Q2 2026

In the vibrant financial landscape of Q2 2026, Conestoga Capital's Micro Cap Composite identified several standout performers, offering crucial insights into strategic investment decisions. Among these, Twist Bioscience Corp. (TWST) emerged as a top leader, reporting an impressive 19% year-over-year revenue growth. This surge is attributed to TWST's cutting-edge DNA synthesis technology and an expanding product portfolio, solidifying its position as a market leader. This performance reaffirms our conviction in companies at the forefront of technological innovation and market expansion. Concurrently, Aortic (AORT) continues to present compelling long-term growth prospects, driven by its expanding aortic product line and robust development pipeline, indicating sustained innovation and market penetration. Furthermore, Palomar Holdings, Inc. (PLMR) remains a favored holding, distinguished by its disciplined underwriting, a diverse array of specialty insurance products, and a proven track record of effectively allocating capital to promising growth avenues.

However, the quarter also necessitated strategic adjustments within the portfolio. The position in N-able (NABL) was reevaluated due to a shift towards a more concentrated software portfolio, prioritizing businesses with superior long-term growth and return potential. This decision reflects an ongoing commitment to optimizing the portfolio for enduring value creation. Similarly, the divestment of US Physical Therapy (USPH) was prompted by escalating labor costs, regulatory uncertainties regarding reimbursement, and a slowdown in margin expansion, which collectively tempered our long-term return expectations for the company. These decisive actions highlight a proactive management approach, ensuring that the composite remains agile and responsive to evolving market conditions and internal performance metrics.

This quarter's activities underscore the critical importance of a meticulous, long-term investment philosophy focused on identifying high-quality small-capitalization growth companies. By concentrating on businesses poised for sustained expansion across various economic conditions, we aim to capitalize on the often-overlooked opportunities within the micro-cap market. The objective is to leverage thorough analysis, distinguishing truly promising ventures from those susceptible to short-term market noise, thereby generating superior returns for our investors.